 |
phosphoinositide-3-kinase delta inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-23 00:00:00 |
| Sponsor | TG Therapeutics, Inc.;3 Columbus Circle, 15th Floor;New York, New York, 10019 |
